RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries
Low- and middle-income countries (LMICs) endure an asymmetrically high burden of worldwide disease and death caused by chronic respiratory diseases (CRDs), i.e., asthma, emphysema, bronchiectasis, and post-tuberculosis lung disease (PTLD). CRDs are firmly related with indigence, infectious diseases,...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2021.757089/full |
_version_ | 1797224825476874240 |
---|---|
author | Ling-Hui Zeng Musaddique Hussain Shahzada Khurram Syed Malik Saadullah Qurratulain Jamil Ali M. Alqahtani Taha Alqahtani Nadia Akram Imran Ahmad Khan Sajida Parveen Tehreem Fayyaz Mobeen Fatima Saira Shaukat Najia Shabbir Mehwish Fatima Aisha Kanwal Muhammad Qasim Barkat Ximei Wu |
author_facet | Ling-Hui Zeng Musaddique Hussain Shahzada Khurram Syed Malik Saadullah Qurratulain Jamil Ali M. Alqahtani Taha Alqahtani Nadia Akram Imran Ahmad Khan Sajida Parveen Tehreem Fayyaz Mobeen Fatima Saira Shaukat Najia Shabbir Mehwish Fatima Aisha Kanwal Muhammad Qasim Barkat Ximei Wu |
author_sort | Ling-Hui Zeng |
collection | DOAJ |
description | Low- and middle-income countries (LMICs) endure an asymmetrically high burden of worldwide disease and death caused by chronic respiratory diseases (CRDs), i.e., asthma, emphysema, bronchiectasis, and post-tuberculosis lung disease (PTLD). CRDs are firmly related with indigence, infectious diseases, and other non-communicable diseases (NCDs) and add to complex multi-disease with great impact on the lives and livelihood of those affected. The pertinence of CRDs to health and demographic wellbeing is relied upon to increment in the long time ahead, as expectations of life rise and the contending dangers of right on time youth mortality and irresistible infections level. The WHO has distinguished the counteraction and control of NCDs as an earnest improvement issue and crucial for the sustainable development goals (SDSs) by 2030. In this review, we center on CRDs in LMICs. We examine the early life roots of CRDs, challenges in their avoidance, identification and administration in LMICs, and the pathways to resolve for accomplish valid widespread wellbeing inclusion. |
first_indexed | 2024-04-24T13:59:16Z |
format | Article |
id | doaj.art-a64efbafef8a40eca067165cf8f5aea2 |
institution | Directory Open Access Journal |
issn | 2296-2565 |
language | English |
last_indexed | 2024-04-24T13:59:16Z |
publishDate | 2022-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Public Health |
spelling | doaj.art-a64efbafef8a40eca067165cf8f5aea22024-04-03T13:37:40ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-02-01910.3389/fpubh.2021.757089757089RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income CountriesLing-Hui Zeng0Musaddique Hussain1Shahzada Khurram Syed2Malik Saadullah3Qurratulain Jamil4Ali M. Alqahtani5Taha Alqahtani6Nadia Akram7Imran Ahmad Khan8Sajida Parveen9Tehreem Fayyaz10Mobeen Fatima11Saira Shaukat12Najia Shabbir13Mehwish Fatima14Aisha Kanwal15Muhammad Qasim Barkat16Ximei Wu17Department of Pharmacology, Zhejiang University City College, Hangzhou, ChinaDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Basic Medical Sciences, School of Health Sciences, University of Management and Technology Lahore, Lahore, PakistanDepartment of Pharmaceutical Chemistry, Government College University, Faisalabad, PakistanDepartment of Pharmacy Practice, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi ArabiaDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi ArabiaDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, PakistanDepartment of Pharmacology, Zhejiang University City College, Hangzhou, ChinaDepartment of Pharmacology, Zhejiang University City College, Hangzhou, ChinaLow- and middle-income countries (LMICs) endure an asymmetrically high burden of worldwide disease and death caused by chronic respiratory diseases (CRDs), i.e., asthma, emphysema, bronchiectasis, and post-tuberculosis lung disease (PTLD). CRDs are firmly related with indigence, infectious diseases, and other non-communicable diseases (NCDs) and add to complex multi-disease with great impact on the lives and livelihood of those affected. The pertinence of CRDs to health and demographic wellbeing is relied upon to increment in the long time ahead, as expectations of life rise and the contending dangers of right on time youth mortality and irresistible infections level. The WHO has distinguished the counteraction and control of NCDs as an earnest improvement issue and crucial for the sustainable development goals (SDSs) by 2030. In this review, we center on CRDs in LMICs. We examine the early life roots of CRDs, challenges in their avoidance, identification and administration in LMICs, and the pathways to resolve for accomplish valid widespread wellbeing inclusion.https://www.frontiersin.org/articles/10.3389/fpubh.2021.757089/fullasthmaCOPDtuberculosisbronchiectasisemphysema–pneumonia–bronchiolitis–smoking–fibrosis–histiocytosis |
spellingShingle | Ling-Hui Zeng Musaddique Hussain Shahzada Khurram Syed Malik Saadullah Qurratulain Jamil Ali M. Alqahtani Taha Alqahtani Nadia Akram Imran Ahmad Khan Sajida Parveen Tehreem Fayyaz Mobeen Fatima Saira Shaukat Najia Shabbir Mehwish Fatima Aisha Kanwal Muhammad Qasim Barkat Ximei Wu RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries Frontiers in Public Health asthma COPD tuberculosis bronchiectasis emphysema–pneumonia–bronchiolitis–smoking–fibrosis–histiocytosis |
title | RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries |
title_full | RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries |
title_fullStr | RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries |
title_full_unstemmed | RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries |
title_short | RETRACTED: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries |
title_sort | retracted revamping of chronic respiratory diseases in low and middle income countries |
topic | asthma COPD tuberculosis bronchiectasis emphysema–pneumonia–bronchiolitis–smoking–fibrosis–histiocytosis |
url | https://www.frontiersin.org/articles/10.3389/fpubh.2021.757089/full |
work_keys_str_mv | AT linghuizeng retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT musaddiquehussain retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT shahzadakhurramsyed retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT maliksaadullah retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT qurratulainjamil retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT alimalqahtani retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT tahaalqahtani retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT nadiaakram retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT imranahmadkhan retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT sajidaparveen retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT tehreemfayyaz retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT mobeenfatima retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT sairashaukat retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT najiashabbir retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT mehwishfatima retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT aishakanwal retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT muhammadqasimbarkat retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries AT ximeiwu retractedrevampingofchronicrespiratorydiseasesinlowandmiddleincomecountries |